reference/13595944

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/13595944

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	6890
issn	1838-7640
issueIdentifier	14
pageRange	6873-6890
publicationName	Theranostics
startingPage	6873
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a500274ddff6e3ece320321eaa155c72
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d083af992003e7a623feba37e9508ff4 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2bb4658c80dbc0d82d9883ae789beb0a http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_255823c85fad514e8e3168b2ad75ba2b http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_dcbd0e819edfe5623bf284071afca51e http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_318e9d233917c440252e1a0f60575ca4
bibliographicCitation	Li X, Gera L, Zhang S, Chen Y, Lou L, Wilson LM, Xie ZR, Sautto G, Liu D, Danaher A, Mamouni K, Yang Y, Du Y, Fu H, Kucuk O, Osunkoya AO, Zhou J, Wu D. Pharmacological inhibition of noncanonical EED-EZH2 signaling overcomes chemoresistance in prostate cancer. Theranostics. 2021;11(14):6873–90. PMID: 34093859; PMCID: PMC8171087.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3d4b5936d7f7ff6af6efc9cc2d846b1b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a5b92823dcb113704ea568576c65f8cb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_26af008a93e6a56d8c3bd3d1d6e2aa76 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0a618dd7b9ccf6aeb441f870cfe9c97c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2cfbde94815168d7a0463c200e38e763 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4fead195e84305e4eeedc00d1a1fca58 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e473777f79254cf8fc3cf7bfb2124e41 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_72033fd57bc00a44ef4b214bef24a74e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_89718696b7066523167e2669fd930250 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bd5f91b483971c2320383806f58edaf6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_07332cab3e494f8ff2fd72ec4b21414a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bad84955ffdbe91fd4741abd4b921656 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5e11d5de60c5ef4e5e046d0091722eb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c28f9d2cca549461f89050f5c4973fe4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7f34b1d7c25021a9b6300ae91a0528a1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fb5bb7097289e5deddd4bda2a80f12ba http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_06fd65473bbd61d1e1ea8a0a5b4543af
date	2021
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC8171087 https://pubmed.ncbi.nlm.nih.gov/34093859 https://doi.org/10.7150/thno.49235
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/38958 https://portal.issn.org/resource/ISSN/1838-7640
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Pharmacological inhibition of noncanonical EED-EZH2 signaling overcomes chemoresistance in prostate cancer
discusses	http://id.nlm.nih.gov/mesh/M0477916 http://id.nlm.nih.gov/mesh/M000639155 http://id.nlm.nih.gov/mesh/M0184558 http://id.nlm.nih.gov/mesh/M0442870 http://id.nlm.nih.gov/mesh/M0027659 http://id.nlm.nih.gov/mesh/M000645006 http://id.nlm.nih.gov/mesh/M0499463 http://id.nlm.nih.gov/mesh/M0229085 http://id.nlm.nih.gov/mesh/M0296656 http://id.nlm.nih.gov/mesh/M0501360 http://id.nlm.nih.gov/mesh/M000613664 http://id.nlm.nih.gov/mesh/M0446233 http://id.nlm.nih.gov/mesh/M0001483
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D055808Q000379 http://id.nlm.nih.gov/mesh/D000970Q000494 http://id.nlm.nih.gov/mesh/D000970Q000737 http://id.nlm.nih.gov/mesh/D011471Q000188 http://id.nlm.nih.gov/mesh/D019008 http://id.nlm.nih.gov/mesh/D000071221Q000378 http://id.nlm.nih.gov/mesh/D001859Q000188 http://id.nlm.nih.gov/mesh/D063151Q000037
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D001859Q000378 http://id.nlm.nih.gov/mesh/D004357 http://id.nlm.nih.gov/mesh/D063151Q000737 http://id.nlm.nih.gov/mesh/D020128 http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D000971Q000494 http://id.nlm.nih.gov/mesh/D002470Q000187 http://id.nlm.nih.gov/mesh/D015398Q000187 http://id.nlm.nih.gov/mesh/D023041 http://id.nlm.nih.gov/mesh/D011471Q000473 http://id.nlm.nih.gov/mesh/D018435Q000378 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D011471Q000378 http://id.nlm.nih.gov/mesh/D000077143Q000627 http://id.nlm.nih.gov/mesh/D000077022Q000378 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D050796Q000378 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000077143Q000494 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D001859Q000556 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D063151Q000378 http://id.nlm.nih.gov/mesh/D044786Q000378
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_132a8504e7423e57e5565c4615cd0cd2 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c3addd02e769f33d86f94bb13502ccd5 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c2b3a5ba99bc94e77229bab735b7776f http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23676225 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a608a24ed70d4c1103ee78f2da5d69b4 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b40ee0ec9bef584b0cf5b10a893da5ed

Total number of triples: 97.